| 000 | 02501 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250514060628.0 | ||
| 264 | 0 | _c20030523 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(03)01291-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThapaliya, Sharada | |
| 245 | 0 | 0 |
_aAn endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cFeb 2003 |
||
| 300 |
_a129-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApamin _xpharmacology |
| 650 | 0 | 4 |
_aBiological Factors _xphysiology |
| 650 | 0 | 4 |
_aCharybdotoxin _xpharmacology |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xinnervation |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpoprostenol _xpharmacology |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xpharmacology |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMesenteric Arteries _xdrug effects |
| 650 | 0 | 4 | _aMesocricetus |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNeuromuscular Junction _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOuabain _xpharmacology |
| 650 | 0 | 4 |
_aPinacidil _xpharmacology |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xphysiology |
| 650 | 0 | 4 |
_aSynaptic Transmission _xphysiology |
| 650 | 0 | 4 |
_aTetraethylammonium _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 |
_aUridine Triphosphate _xpharmacology |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aMatsuyama, Hayato | |
| 700 | 1 | _aEl-Mahmoudy, AbuBakr | |
| 700 | 1 | _aShimizu, Yasutake | |
| 700 | 1 | _aTakewaki, Tadashi | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 461 _gno. 2-3 _gp. 129-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(03)01291-3 _zAvailable from publisher's website |
| 999 |
_c12383568 _d12383568 |
||